Golden Helix Inc.
Company Snapshot
Company Overview
Golden Helix has been delivering bioinformatics solutions for the advancement of translational medicine and life science research for over 20 years. The firm’s innovative technologies and analytic services empower healthcare professionals and scientists at all levels to derive meaning from the rapidly rising volumes of genomic data produced from microarrays and NGS. With these solutions, hundreds of the world’s top biotech, pharmaceutical and academic research organizations can harness the full potential of genomics to know the cause of disease, improve the safety and efficacy of drugs, develop genomic diagnostics and advance the quest for personalized medicine. The company products and services have been cited in around 1,000s of peer-reviewed publications.
Golden Helix offers the following bioinformatics products for clinical applications: VarSeq (variant analysis software for gene panels, exomes and whole genomes); VSClinical (clinical interpretation of variants); VS-CNV (direct calls of CNVs in targeted regions); VSPipeline (clinical workflow for CLIA and CAP certified analysis); VSReports (customized clinical report of analysis data); and VSWarehouse (a warehouse for NGS variant call sites, clinical reports and catalogs of variant assessments).
Company's Business Segments
- Bioinformatics Solutions : The company provides software for healthcare professionals and scientists at all levels to analyze and interpret NGS data efficiently and effectively.
Applications/End User Industries
- Commercial Testing Labs
- Hospital Labs
- Human Genetic Research
- Country-Wide Genome Projects
- Pharmaceutical R&D
- GWAS Research